Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
Sign Up to like & getrecommendations! Published in 2018 at "Dermatology and Therapy"
DOI: 10.1007/s13555-018-0230-9
Abstract: Psoriasis is a chronic, inflammatory, lifelong disease with a high prevalence (afflicting approximately 1–5% of the population worldwide) and is associated with significant morbidity. The introduction of biologic therapies has improved the management of this… read more here.
Keywords: patients psoriasis; dermatology; treatment; biosimilar drugs ... See more keywords
Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Global Oncology"
DOI: 10.1200/jgo.2016.008342
Abstract: Biologic therapy is one of the great medical achievements of the last decades. More than 250 of the commercially available products and more than half of the oncologic therapies in development are biologic, and some… read more here.
Keywords: drugs would; biosimilar drugs; development; oncology ... See more keywords
BIOSTATISTIC, LEGISLATIV AND ETHICAL PROBLEMS OF COMPARATIVE CLINICAL STUDIES. I. GENERIC AND BIOSIMILAR DRUGS CASE
Sign Up to like & getrecommendations! Published in 2018 at "FARMACIA"
DOI: 10.31925/farmacia.2018.6.2
Abstract: This paper presents an ethical approach of the clinical studies, biostatistical and legislative aspects for testing generics and biosimilars and the valuation of the obtained results in clinical practice and health politics. Both generics and… read more here.
Keywords: bioequivalence; clinical studies; biostatistic legislativ; case ... See more keywords